|
1
|
Taymans SE, Pack S, Pak E, Torpy DJ,
Zhuang Z and Stratakis CA: Human CYP11B2 (aldosterone synthase)
maps to chromosome 8q24.3. J Clin Endocrinol Metab. 83:1033–1036.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Russo P, Siani A, Venezia A, Iacone R,
Russo O, Barba G, D’Elia L, Cappuccio FP and Strazzullo P:
Interaction between the C(-344)T polymorphism of CYP11B2 and age in
the regulation of blood pressure and plasma aldosterone levels:
cross-sectional and longitudinal findings of the Olivetti
Prospective Heart Study. J Hypertens. 20:1785–1792. 2002.
View Article : Google Scholar
|
|
3
|
Zhang GX, Wang BJ, Ouyang JZ, Deng XY, Ma
X, Li HZ, Wu Z, Liu SL, Xu H and Zhang X: Polymorphisms in CYP11B2
and CYP11B1 genes associated with primary hyperaldosteronism.
Hyperten Res. 33:478–484. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ranade K, Wu KD, Risch N, Olivier M, Pei
D, Hsiao CF, Chuang LM, Ho LT, Jorgenson E, Pesich R, et al:
Genetic variation in aldosterone synthase predicts plasma glucose
levels. Proc Natl Acad Sci USA. 98:13219–13224. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bellili NM, Foucan L, Fumeron F, Mohammedi
K, Travert F, Roussel R, Balkau B, Tichet J and Marre M:
Associations of the -344 T>C and the 3097 G>A polymorphisms
of CYP11B2 gene with hypertension, type 2 diabetes, and metabolic
syndrome in a French population. Am J Hypertens. 23:660–667.
2010.
|
|
6
|
Kupari M, Hautanen A, Lankinen L, Koskinen
P, Virolainen J, Nikkila H and White PC: Associations between human
aldosterone synthase (CYP11B2) gene polymorphisms and left
ventricular size, mass, and function. Circulation. 97:569–575.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sookoian S, Gianotti TF and Pirola CJ:
Role of the C-344T aldosterone synthase gene variant in left
ventricular mass and left ventricular structure-related phenotypes.
Heart. 94:903–910. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pojoga L, Gautier S, Blanc H, Guyene TT,
Poirier O, Cambien F and Benetos A: Genetic determination of plasma
aldosterone levels in essential hypertension. Am J Hypertens.
11:856–860. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
White PC, Hautanen A and Kupari M:
Aldesterone synthase (CYP11B2) polymorphisms and cardiovascular
function. Endocr Res. 24:797–804. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hautanen A, Toivanen P, Manttari M,
Tenkanen L, Kupari M, Manninen V, Kayes KM, Rosenfeld S and White
PC: Joint effects of an aldosterone synthase (CYP11B2) gene
polymorphism and classic risk factors on risk of myocardial
infarction. Circulation. 100:2213–2218. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tsukada K, Ishimitsu T, Teranishi M,
Saitoh M, Yoshii M, Inada H, Ohta S, Akashi M, Minami J, Ono H, et
al: Positive association of CYP11B2 gene polymorphism with genetic
predisposition to essential hypertension. J Hum Hypertens.
16:789–793. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gu D, Ge D, He J, Li B, Chen J, Liu D,
Chen J and Chen R: Haplotypic analyses of the aldosterone synthase
gene CYP11B2 associated with stage-2 hypertension in northern Han
Chinese. Clin Genet. 66:409–416. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Komiya I, Yamada T, Takara M, Asawa T,
Shimabukuro M, Nishimori T and Takasu N: Lys(173)Arg and -344T/C
variants of CYP11B2 in Japanese patients with low-renin
hypertension. Hypertension. 35:699–703. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lim PO, Macdonald TM, Holloway C, Friel E,
Anderson NH, Dow E, Jung RT, Davies E, Fraser R and Connell JM:
Variation at the aldosterone synthase (CYP11B2) locus contributes
to hypertension in subjects with a raised aldosterone-to-renin
ratio. J Clin Endocrinol Metab. 87:4398–4402. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grundy SM, Cleeman JI, Daniels SR, Donato
KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith
SC Jr, et al: Diagnosis and management of the metabolic syndrome:
an American Heart Association/National Heart, Lung, and Blood
Institute Scientific Statement. Circulation. 112:2735–2752. 2005.
View Article : Google Scholar
|
|
16
|
Hedrick PW: Gametic disequilibrium
measures: proceed with caution. Genetics. 117:331–341.
1987.PubMed/NCBI
|
|
17
|
Shibata H, Suzuki H, Ogishima T, Ishimura
Y and Saruta T: Significance of steroidogenic enzymes in the
pathogenesis of adrenal tumour. Acta Endocrinol (Copenh).
128:235–242. 1993.PubMed/NCBI
|
|
18
|
Russo P, Lauria F, Loguercio M, Barba G,
Arnout J, Cappuccio FP, de Lorgeril M, Donati MB, Iacoviello L,
Krogh V, et al: -344C/T variant in the promoter of the aldosterone
synthase (CYP11B2) is associated with metabolic syndrome in men. Am
J Hypertens. 20:218–222. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Imrie H, Freel M, Mayosi BM, Davies E,
Fraser R, Ingram M, Cordell HJ, Farrall M, Avery PJ, Watkins H, et
al: Association between aldosterone production and variation in the
11beta-hydroxylase (CYP11B1) gene. J Clin Endocrionol Metab.
91:5051–5056. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rajput C, Arif E, Vibhuti A, Stobdan T,
Khan AP, Norboo T, Afrin F and Qadar Pasha MA: Predominance of
interaction among wild-type alleles of CYP11B2 in Himalayan natives
associates with high-altitude adaption. Biochem Biophys Res Commun.
348:735–740. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qi Y, Niu W, Zhu T, Zhou W and Qiu C:
Synergistic effect of the genetic polymorphisms of the
renin-angiotensin-aldosterone system on high-altitude pulmonary
edema: a study from Qinghai-Tibet altitude. Eur J Epidemiol.
23:143–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen B, Nie S, Luo S, Zhang W and Xiao C:
Association of the human CYP11B2 gene and essential hypertension in
southwest Han Chinese population: a haplotype-based case-control
study. Clin Exp Hypertens. 33:106–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
